San Juan A F, Chamorro-Viña C, Maté-Muñoz J-L, Fernández del Valle M, Cardona C, Hernández M, Madero L, Pérez M, Ramírez M, Lucia A
Exercise Physiology Laboratory, Universidad Europea de Madrid, Madrid, Spain.
Int J Sports Med. 2008 Feb;29(2):163-7. doi: 10.1055/s-2007-964908. Epub 2007 Sep 18.
The purpose of this study was to determine if the functional capacity and quality of life of children receiving treatment against acute lymphoblastic leukemia (ALL) is decreased compared to healthy age and gender-matched children. Functional capacity was assessed with a number of measurements as the peak oxygen uptake (VO2peak) and ventilatory threshold determined during a ramp treadmill test, functional mobility (Timed Up and Down Stairs test [TUDS]) and ankle dorsiflexion passive and active range of motion (passive and active DF-ROM, respectively). Quality of life (QOL) was determined with the Spanish version of the Child Report Form of the Child Health and Illness Profile-Child Edition (CHIP-CE/CRF). Fifteen children (9 boys, 6 girls; mean [SD] age: 6.8 +/- 3.1 years) receiving maintenance therapy against ALL were studied and fifteen, nonathletic healthy children (9 boys, 6 girls; 6.9 +/- 3.3 years) were selected as controls. The mean values of VO2peak and active DF-ROM were significantly (p < 0.05) lower in patients (25.3 +/- 6.5 ml . kg (-1) . min (-1) vs. 31.9 +/- 6.8 ml . kg (-1) . min (-1) in controls and 19.6 +/- 8.0 degrees vs. 24.1 +/- 5.0 degrees , respectively). Children's self report of satisfaction (with self and health) (p < 0.05), comfort (concerning emotional and physical symptoms and limitations) (p < 0.01) and resilience (positive activities that promote health) (p < 0.01) were significantly decreased in patients with ALL. In summary, children receiving treatment against ALL have overall lower functional capacity and QOL than healthy children. However, their physical condition and health status are sufficiently high to allow them to participate in physical activities and supervised exercise programs.
本研究的目的是确定与年龄和性别匹配的健康儿童相比,接受急性淋巴细胞白血病(ALL)治疗的儿童的功能能力和生活质量是否下降。通过多种测量方法评估功能能力,如在递增式跑步机测试中测定的峰值摄氧量(VO2peak)和通气阈值、功能活动能力(定时起立行走测试[TUDS])以及踝关节背屈被动和主动活动范围(分别为被动和主动DF-ROM)。生活质量(QOL)通过儿童健康与疾病状况简表-儿童版(CHIP-CE/CRF)的西班牙文版儿童报告表来确定。对15名接受ALL维持治疗的儿童(9名男孩,6名女孩;平均[标准差]年龄:6.8±3.1岁)进行了研究,并选取了15名不运动的健康儿童(9名男孩,6名女孩;6.9±3.3岁)作为对照。患者的VO2peak和主动DF-ROM的平均值显著较低(p<0.05)(患者分别为25.3±6.5 ml·kg⁻¹·min⁻¹,对照组为31.9±6.8 ml·kg⁻¹·min⁻¹;患者为19.6±8.0度,对照组为24.1±5.0度)。ALL患者在自我满意度(对自身和健康)(p<0.05)、舒适度(关于情绪和身体症状及限制)(p<0.01)和恢复力(促进健康的积极活动)(p<0.01)方面的自我报告显著降低。总之,接受ALL治疗的儿童总体功能能力和生活质量低于健康儿童。然而,他们的身体状况和健康状态足以让他们参与体育活动和有监督的锻炼计划。